AR
Ayyavu Rajavel
About Ayyavu Rajavel
Data last updated:
Ayyavu Rajavel is an Alternate Director at Saimirra Innopharm Private Limited (since 2012), Alternate Director at Nuray Chemicals Private Limited (since 2012) and Director at Scitus Pharma Services Private Limited (since 2017), and holds 8 more current directorships. The companies operate in Pharma, Infrastructure and Utilities and Healthcare. The 10 current companies with reported revenue have a combined latest revenue of ₹342 Cr; the largest is Saimirra Innopharm Private Limited at ₹133 Cr (FY 2025). Earlier, Ayyavu Rajavel was a Director at Par Biosciences Private Limited (2012–2015) and Alternate Director at Delvin Formulations Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saimirra Innopharm Private Limited U24232TN2000PTC044315 | Alternate Director | 22 Oct 2012 | 2000 | ₹133 Cr (FY 2025) | Active |
 Nuray Chemicals Private Limited U24110TN2012PTC086320 | Alternate Director | 14 Jun 2012 | 2012 | ₹122 Cr (FY 2025) | Active |
 Scitus Pharma Services Private Limited U74999TN2017PTC118805 | Director | 26 Sep 2017 | 2017 | ₹43.45 Cr (FY 2025) | Active |
 Novitium Labs Private Limited U74999TN2016PTC112516 | Director | 15 Sep 2016 | 2016 | ₹33.80 Cr (FY 2025) | Active |
| Esjay Pharma Private Limited U24290TN2022PTC155725 | Director | 30 Sep 2022 | 2022 | ₹3.90 Cr (FY 2024) | Active |
| Sthree Chemicals Private Limited U24299TN2020PTC140109 | Director | 15 Dec 2020 | 2020 | ₹3.11 Cr (FY 2024) | Active |
| Sthree Pharmaceuticals Private Limited U24297TN2015PTC101802 | Director | 06 Oct 2017 | 2015 | ₹1.46 Cr (FY 2024) | Active |
| Tindivanam Pharma Park Association U85300TN2023NPL158185 | Director | 27 Dec 2024 | 2023 | ₹61.2 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Par Biosciences Private Limited U24233TN2012PTC086326 | Director | 15 Jun 2012 | 2012 | ₹3.31 Cr (FY 2025) | Active |
 Delvin Formulations Private Limited U24100TN2009PTC072376 | Alternate Director | 13 Aug 2009 | 2009 | ₹30.87 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ayyavu Rajavel
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ayyavu Rajavel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayyavu Rajavel
Ayyavu Rajavel currently holds 11 directorships: Saimirra Innopharm Private Limited (Alternate Director, since 22 Oct 2012, revenue ₹133 Cr (FY 2025)); Nuray Chemicals Private Limited (Alternate Director, since 14 Jun 2012, revenue ₹122 Cr (FY 2025)); Scitus Pharma Services Private Limited (Director, since 26 Sep 2017, revenue ₹43.45 Cr (FY 2025)); Novitium Labs Private Limited (Director, since 15 Sep 2016, revenue ₹33.80 Cr (FY 2025)); Esjay Pharma Private Limited (Director, since 30 Sep 2022, revenue ₹3.90 Cr (FY 2024)); and 6 more.
Ayyavu Rajavel was first appointed on 13 Aug 2009 as Alternate Director at Delvin Formulations Private Limited. The most recent appointment on record is 18 Mar 2025 at Ayra Projects' Private Limited.
The 10 current companies of Ayyavu Rajavel that report revenue have a combined latest revenue of ₹342 Cr: Saimirra Innopharm Private Limited ₹133 Cr (FY 2025); Nuray Chemicals Private Limited ₹122 Cr (FY 2025); Scitus Pharma Services Private Limited ₹43.45 Cr (FY 2025); Novitium Labs Private Limited ₹33.80 Cr (FY 2025); Esjay Pharma Private Limited ₹3.90 Cr (FY 2024); and 5 more.
Ayyavu Rajavel held 2 earlier board appointments: Par Biosciences Private Limited (Director, 15 Jun 2012 to 15 Jan 2015); Delvin Formulations Private Limited (Alternate Director, from 13 Aug 2009).
The current boards of Ayyavu Rajavel's companies include Abhishek Jain (Saimirra Innopharm Private Limited), Anushree Manmohan Chandak (Saimirra Innopharm Private Limited), Bernice Sugirtha (Saimirra Innopharm Private Limited), Jaganathan Jayaseelan (Saimirra Innopharm Private Limited), Shanmugam Muthusamy (Saimirra Innopharm Private Limited), Thanigainathan Thirumurugan (Saimirra Innopharm Private Limited), among others.